Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System
(2019) In Blood Purification 47(44564). p.166-170- Abstract
Background/Aims: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in an international multicentre setting. The system has multiple novel tools aiming to increase accuracy and dose delivery. Methods: Data was prospectively collected from 7 intensive care units in 6 countries. The PrisMax device data logs constituted the raw material and last generation Prismaflex data was used as comparison. Clinical parameters like treatment time, filter life span, downtime as well as prescribed and delivered dose were recorded. Results: PrisMax delivered/prescribed effluent ratios (mean ± SD) 0.92 ± 0.15 vs. Prismaflex ratios 0.85 ± 0.21, p < 0.001; delivered effluent dose (mL/kg/h) was 18.16 ± 12.93 vs.... (More)
Background/Aims: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in an international multicentre setting. The system has multiple novel tools aiming to increase accuracy and dose delivery. Methods: Data was prospectively collected from 7 intensive care units in 6 countries. The PrisMax device data logs constituted the raw material and last generation Prismaflex data was used as comparison. Clinical parameters like treatment time, filter life span, downtime as well as prescribed and delivered dose were recorded. Results: PrisMax delivered/prescribed effluent ratios (mean ± SD) 0.92 ± 0.15 vs. Prismaflex ratios 0.85 ± 0.21, p < 0.001; delivered effluent dose (mL/kg/h) was 18.16 ± 12.93 vs. 10.95 ± 10.96, p < 0.0001; and (Kt/V) 0.76 ± 0.52 vs. 0.44 ± 0.44, p < 0.0001. Moreover, downtime was 27 minutes less for the newer device. Conclusion: The PrisMax CRRT device outperforms its predecessor with regard to dose delivery and accuracy.
(Less)
- author
- Bell, Max ; Broman, Marcus LU ; Joannes-Boyau, Olivier and Ronco, Claudio
- publishing date
- 2019
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Acute kidney injury, Citrate, Continuous hemodiafiltration, Critical care, Dialysis efficiency, Dialysis machine, Hemodiafiltration
- in
- Blood Purification
- volume
- 47
- issue
- 44564
- pages
- 166 - 170
- publisher
- Karger
- external identifiers
-
- pmid:30428467
- scopus:85056892143
- ISSN
- 0253-5068
- DOI
- 10.1159/000494764
- language
- English
- LU publication?
- no
- id
- d066ef84-fc83-45a3-8dfa-af6b11a05366
- date added to LUP
- 2018-11-30 09:17:06
- date last changed
- 2024-09-17 08:52:02
@article{d066ef84-fc83-45a3-8dfa-af6b11a05366, abstract = {{<p>Background/Aims: We assessed how the novel PrisMax continuous renal replacement therapy (CRRT) system performed in an international multicentre setting. The system has multiple novel tools aiming to increase accuracy and dose delivery. Methods: Data was prospectively collected from 7 intensive care units in 6 countries. The PrisMax device data logs constituted the raw material and last generation Prismaflex data was used as comparison. Clinical parameters like treatment time, filter life span, downtime as well as prescribed and delivered dose were recorded. Results: PrisMax delivered/prescribed effluent ratios (mean ± SD) 0.92 ± 0.15 vs. Prismaflex ratios 0.85 ± 0.21, p < 0.001; delivered effluent dose (mL/kg/h) was 18.16 ± 12.93 vs. 10.95 ± 10.96, p < 0.0001; and (Kt/V) 0.76 ± 0.52 vs. 0.44 ± 0.44, p < 0.0001. Moreover, downtime was 27 minutes less for the newer device. Conclusion: The PrisMax CRRT device outperforms its predecessor with regard to dose delivery and accuracy.</p>}}, author = {{Bell, Max and Broman, Marcus and Joannes-Boyau, Olivier and Ronco, Claudio}}, issn = {{0253-5068}}, keywords = {{Acute kidney injury; Citrate; Continuous hemodiafiltration; Critical care; Dialysis efficiency; Dialysis machine; Hemodiafiltration}}, language = {{eng}}, number = {{44564}}, pages = {{166--170}}, publisher = {{Karger}}, series = {{Blood Purification}}, title = {{Comparison of the Accuracy of the Novel PrisMax Continuous Renal Replacement Therapy System to the Classic Prismaflex System}}, url = {{http://dx.doi.org/10.1159/000494764}}, doi = {{10.1159/000494764}}, volume = {{47}}, year = {{2019}}, }